MedCision, LLC v. Ehrhardt

CourtDistrict Court, N.D. California
DecidedJanuary 6, 2025
Docket3:24-cv-01146
StatusUnknown

This text of MedCision, LLC v. Ehrhardt (MedCision, LLC v. Ehrhardt) is published on Counsel Stack Legal Research, covering District Court, N.D. California primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
MedCision, LLC v. Ehrhardt, (N.D. Cal. 2025).

Opinion

1 2 3 4 5 6 7 UNITED STATES DISTRICT COURT 8 NORTHERN DISTRICT OF CALIFORNIA 9 MEDCISION, LLC, 10 Case No. 24-cv-01146-RS Plaintiff, 11 v. ORDER AND OPINION AFFIRMING 12 DISMISSAL EHRHARDT, 13 Defendant. 14

15 I. INTRODUCTION 16 This appeal arises from two related adversarial proceedings brought by Plaintiff and 17 Appellant Medcision, LLC against Defendants Rolf Ehrhardt and Ron DiNocco. The Bankruptcy 18 Court dismissed the adversarial proceedings for both lack of prosecution and for failure to comply 19 with a court order. MedCision avers the Bankruptcy Court abused its discretion by doing so. 20 Specifically, MedCision contends the Bankruptcy Court failed adequately to warn of the 21 possibility of terminating sanctions, to consider less drastic sanctions, and to consider 22 MedCision’s reasonable explanations for delay.1 23 These proceedings began in 2019, and MedCision had well over a year to participate in the 24 discovery process and prepare for trial. It did not do so. Based on that failure, and the failure to 25

26 1 MedCision requests judicial notice of the statement it filed in the underlying bankruptcy proceeding and the bankruptcy court’s order setting a hearing in the bankruptcy proceeding for the 27 same date and time as the adversary proceedings. Dkt. No. 18. This request for judicial notice is 1 comply with a pretrial order, the Bankruptcy Court did not abuse its discretion in dismissing this 2 action.2 Therefore, the dismissal order is affirmed. 3 II. BACKGROUND 4 A. Procedural Background 5 In December 2019, MedCision filed its first adversary proceedings against Defendants, its 6 former officers, and against its outside directors for breach of their fiduciary duties. MedCision 7 alleged, among other things, that the board of directors approved improper bonus payments, 8 severance, and compensation to Defendants, all under Defendants’ direction. In MedCision’s other 9 adversary proceeding, a related action against Ehrhardt, Plaintiff brought claims for avoidance and 10 preference of transfers, avoidance and preference of post-petition transfers, and an open book 11 account. 12 In August 2020, the Bankruptcy Court dismissed the first adversarial proceeding as to the 13 outside directors and entered final judgment as to those defendants. As to the remaining 14 defendants, the Court denied in part and granted in part their motion to dismiss. 15 MedCision appealed the August 2020 judgment in favor of its outside directors. The 16 adversary proceedings were stayed for nearly two years while the appeal was pending. In August 17 2021, this Court affirmed the Bankruptcy’s Court’s dismissal of the outside directors. MedCision 18 appealed to the Ninth Circuit, but eventually voluntarily dismissed that appeal. 19 With the appeal proceedings concluded by June 2022, the Bankruptcy Court set several 20 scheduling conferences and a discovery plan to continue proceedings. In December 2022, the 21 Court issued a scheduling order which set discovery and pre-trial deadlines, leaving the date of 22 trial to be determined. The Court stated parties could stipulate to extend the deadline to conduct 23 nonexpert discovery, while other deadlines could be extended only by court order. In June 2023, 24

25 2 It is unnecessary to rule on Plaintiff’s other alleged shortcomings, raised by Defendants on appeal, including omission of a jurisdictional statement in its opening brief and failure properly to 26 serve copies of its filings on DiNocco, who is litigating pro per. These allegations affirm Plaintiff’s general negligence in prosecuting this matter, but are not relevant to the bankruptcy 27 court’s reasoning in dismissing the adversary proceedings. 1 the Bankruptcy Court rejected in part parties’ request to extend some of the discovery deadlines. 2 With the expert discovery deadline set for August 31, 2023, and the deadline for any motions to 3 compel on September 24, 2023, the Court eventually set the pre-trial conference for December 14, 4 2023. 5 In the September 29, 2023 order setting the pretrial conference, the Court directed the 6 parties to file statements by December 7, 2023 addressing trial-related issues, including when 7 parties would be ready for trial. Neither MedCision nor Defendants filed statements by that 8 December 7, 2023 deadline. On December 7, MedCision filed a status conference statement in the 9 underlying bankruptcy case in advance of a status hearing, also on December 14, related to the 10 bankruptcy proceedings. 11 B. Dismissal Orders 12 On December 8, 2023, the Bankruptcy Court issued essentially the same Order to Show 13 Cause in both adversary proceedings after all parties failed to comply with the Order directing 14 them to file statements regarding trial readiness. The Order specifically warned of monetary 15 sanctions for failure to file the statements. Relying on Federal Rule of Civil Procedure 16(f)(1)(C) and Federal Rule of Bankruptcy Procedure 7016(a), which permits courts to “issue any just 16 orders” if parties fail to “obey a scheduling or other pretrial order,” the court noted that it “has 17 broad discretion in crafting remedies for a party’s failure to comply with a scheduling order.” Dkt. 18 No. 16-1, at 155, 159. “Such remedies may include, but are not limited to, dismissal of the action 19 or proceeding in whole or in part.” Id. The Bankruptcy Court noted, in addition to the parties’ 20 failure to comply with the order, “the parties have not been diligent in prosecuting and defending 21 this action.” Dkt. No. 16-1, at 155, 159. 22 MedCision responded to the Orders to Show Cause, explaining its counsel in the adversary 23 proceedings had worked with counsel in the underlying bankruptcy proceeding to prepare a joint 24 status conference statement. MedCision’s counsel in the adversary proceedings believed the joint 25 statement, signed and filed on their behalf in the underlying bankruptcy proceeding, would fulfill 26 their obligation to comply with the bankruptcy court’s pre-trial order in the adversary proceeding. 27 1 As to trial readiness, MedCision’s response explained the parties had engaged in settlement 2 discussions in the first half of 2023, but later had difficulties scheduling Defendants’ depositions. 3 After an initial refusal to appear for depositions, Defendant Ehrhardt’s counsel had stated Ehrhardt 4 was available to be deposed in January 2024, despite the close of discovery. Defendant DiNocco 5 had agreed to sit for a deposition before the discovery deadline passed, but MedCision had not 6 taken any action as to DiNocco before the discovery deadlines closed. In November 2023, when 7 MedCision did reach out to Defendants to attempt to schedule depositions, Defendant DiNocco 8 took the position discovery was closed and declined to stipulate to continue trial or discovery 9 deadlines. Based on these discussions, MedCision stated it was unsure when adversary 10 proceedings would be ready for trial. 11 In Defendants’ response, Ehrhardt’s counsel confirmed the parties would need a 12 continuance to file a summary judgment motion or to complete discovery. Ehrhardt acknowledged 13 MedCision had responded to requests for admissions but had not served documents in response to 14 requests for production and had not substantively responded to requests for special interrogatories. 15 At the show-case hearing on December 14, 2023, the Bankruptcy Court indicated 16 skepticism over Plaintiff’s explanations for delay. “I would dismiss these adversary proceedings 17 with prejudice for lack of prosecution, because it’s absurd. Reserving jurisdiction to enforce my 18 sanctions orders, but it’s absurd that nothing has happened in these cases.” Dkt. No. 16-3, at 146- 47.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
MedCision, LLC v. Ehrhardt, Counsel Stack Legal Research, https://law.counselstack.com/opinion/medcision-llc-v-ehrhardt-cand-2025.